FDA OKs Luminex respiratory-virus test

01/3/2008 | USA Today · American City Business Journals · Reuters

The FDA has granted Luminex Corp. approval to market its xTAG Respiratory Viral Panel test designed to detect 12 respiratory viruses and subtypes within hours. The test, which was developed by Toronto-based unit Luminex Molecular Diagnostics, is the first multiplexed nucleic acid test for respiratory viruses approved by the FDA for in-vitro diagnostic use.

View Full Article in:

USA Today · American City Business Journals · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX